ET bromodomain inhibitor   Click here for help

GtoPdb Ligand ID: 7808

PDB Ligand
Compound class: Synthetic organic
Comment: The chemical structure shown here is the (1S-2R) isomer of the compound ET, this represented the minor product of the synthesis [1], with the major component being the (1S-2S) isomer. Data from the manuscript was produced using the former isomer, simply called ET in the text.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 0
Rotatable bonds 6
Topological polar surface area 78.08
Molecular weight 438.15
XLogP 6.35
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES COC(=O)C(C1N=C(c2ccc(cc2)Cl)c2c(n3c1nnc3C)ccc(c2)OC)CC
Isomeric SMILES COC(=O)[C@@H]([C@@H]1N=C(c2ccc(cc2)Cl)c2c(n3c1nnc3C)ccc(c2)OC)CC
InChI InChI=1S/C23H23ClN4O3/c1-5-17(23(29)31-4)21-22-27-26-13(2)28(22)19-11-10-16(30-3)12-18(19)20(25-21)14-6-8-15(24)9-7-14/h6-12,17,21H,5H2,1-4H3/t17-,21+/m1/s1
InChI Key WGMDCNPABCIZCD-UTKZUKDTSA-N
Bioactivity Comments
Ligand ET binds to WT BRD2(1) and BRD2(2) with Kds of 9 and 17 µM respectively. In line with the experimental hypothesis, ET displayed much lower Kds against the corresponding L/A mutants [BRD2(1)L110A and BRD2(2)L383A] which represents 9120- and 200-fold stronger binding relative to WT. Actual Kds for the mutants are 74 and 86 nM [1]. respectively.
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
bromodomain containing 2 Primary target of this compound Hs Inhibitor Inhibition 4.8 – 5.1 pKd - 1
pKd 4.8 – 5.1 (Kd 1.7x10-5 – 9x10-6 M) The higher affinity interaction is with the BRD2-BD1 domain, the lower affinity with the BRD2-BD2 domain [1]